
Refurbished Medical Equipment Market - Global Outlook & Forecast 2022-2027
Description
Refurbished Medical Equipment Market - Global Outlook & Forecast 2022-2027
The global refurbished medical equipment market is expected to grow at a CAGR of 11.76% during 2022-2027.
MARKET INSIGHTS
Increasing Demand for Medical Equipment in Developing Countries
PRODUCT TYPE INSIGHTS
The global refurbished medical equipment market by product type is segmented into medical imaging, IVD & laboratories, OR, surgical & therapeutic, patient monitoring, cardiology, dental, and others. In 2021, the medical imaging segment dominated the market, accounting for 25.58%. The use of medical diagnostic imaging equipment can resolve between 70 – 80% of diagnostic problems, but nearly 2/3 of the world’s population has no access to diagnostic radiology. Refurbished X-ray machines, ultrasound systems, MRI machines, CT scanners, and nuclear medicine systems (PET, SPECT, and PET/CT) allow healthcare facilities to provide patients with life-saving medical diagnostic imaging services.
The IVD & laboratories equipment segment will likely witness the highest CAGR of 13.14%. Further, the medical imaging equipment segment will account for the highest incremental growth of USD 3.10 billion over the forecast period.
Segmentation by Product Type
Diagnosis & monitoring and treatment & surgical interventions are the key segments in the global refurbished medical equipment market by application. In 2021, the diagnosis & monitoring segment dominated the market with a share of 69.46%, followed by treatment & surgical interventions. Medical equipment is extensively utilized for patients’ diagnosis and treatment. Diagnostic and monitoring applications comprise Cardiology, Urology, Neurology, Orthopedics, Physiology, Emergency Medicine, Oncology, Obstetrics/Gynecology (OB/GYN), and others.
Arizton predicts that the treatment & surgical interventions segment will likely witness the highest CAGR of 12.40%. The diagnosis & monitoring segment will account for the highest incremental growth of USD 9.73 billion over the forecast period.
Segmentation Application
The global refurbished medical equipment market is segmented into hospitals, radiology/medical imaging centers, physicians' offices & dental clinics, clinical & research laboratories, and others by end-user. In 2021, the hospital segment accounted for 37.97% dominating the industry. Arizton predicts that the clinical & research laboratories segment will likely witness the highest CAGR of 12.18%.
The hospital's segment will account for the highest incremental growth of USD 5.24 billion over the forecast period. Hospitals utilize more medical equipment than any other healthcare setting. Diagnostics are the primary screening method in hospitals, which are the first point of contact for any infection and disease. The rising number of people with various infectious diseases encourages physicians in hospitals to use diagnostic imaging equipment, thereby increasing their demand.
Segmentation by End-users
The refurbished medical equipment market has a high potential due to low production and material costs, contribution to containing hospital costs, and high growth potential. North America and Europe are the matured market for refurbished medical equipment. In 2021, North America dominated the global refurbished medical equipment market with a share of 28.24%, followed by Europe, APAC, Latin America, and the Middle East & Africa. Arizton predicts that the APAC segment will likely witness the highest CAGR of 14.45% and the highest incremental growth of USD 4.84 billion over the forecast period. Factors associated with the market growth in the region include constant public and private funding, advancements in diagnostic imaging models, and growing medical awareness.
North American refurbished medical equipment market was valued at USD 4.30 billion in 2021.
The North American region is dominating the global refurbished medical equipment market with the aging population, the prevalence of chronic diseases, growing healthcare expenditure, the need for advanced imaging techniques, the presence of well-established players, and a significant shift towards digital medical equipment. Further, the US accounted for 91.21% of the North American refurbished medical equipment market share. One of the major factors driving the demand for refurbished medical equipment in the US is the increasing diseased population, the increasing access to insurance, and the faster adoption of advanced healthcare instruments for treatments.
Segmentation by Geography
The global refurbished medical equipment market is exceptionally active, with fewer global, regional, and local players offering a wide range of medical equipment. The industry is less competitive, as the key players have gained significant refurbished medical equipment market share compared to other prominent players. The market provides the avenue for cheaper access to healthcare delivery and reduces costs in developing countries where these equipment are purchased for use.
The three major manufacturers in the refurbished medical equipment market, GE Healthcare, Koninklijke Philips, and Siemens Healthineers, have implemented the refurbished process and sold their refurbished medical equipment under distinct brand names. In 2021, North America was the largest regional refurbished medical equipment market. It was primarily attributed to the presence of many private healthcare facilities, the increasing aging population, the high prevalence of various diseases, ongoing reimbursement cuts, and regulatory scenarios for the sale and use of refurbished medical equipment in the US.
Key Vendors
1. What is the expected refurbished medical equipment market size by 2027?
2. What is the growth rate of the global refurbished medical equipment market?
3. Who are the key companies in the global refurbished medical equipment market?
4. What are the latest refurbished medical equipment market trends globally?
5. Which region holds the largest refurbished medical equipment market share globally?
The global refurbished medical equipment market is expected to grow at a CAGR of 11.76% during 2022-2027.
MARKET INSIGHTS
- The global market is growing due to the increasing number of healthcare settings and increased access to healthcare services. The industry is growing due to the high prevalence of several acute and chronic diseases across the globe.
- Refurbishment is the systematic process of making used equipment equal to or better than new. Refurbishment is rebuilding or updating with all new materials, components, or parts to restore their original (or better) working condition and appearance. The global refurbished medical equipment market grew significantly during the pre-pandemic times. However, outbreaks of diseases like bird flu, COVID-19, and Monkeypox create a massive demand for used medical equipment.
- Small & medium-sized hospitals, typically doctor-owned and with less than 100 beds, often cannot afford to buy new high-end equipment. These facilities prefer refurbished equipment of reputed brands that will cost less but perform well for a few years without complaints. These could be young doctors who become self-employed after using such devices in large hospitals. They may be familiar with the equipment models, but they are short on a budget in the early stages of the business. Also, tier 3 cities may have enough patients without enough ability to pay. Such locations cannot provide sufficient return on investment (ROI) for new equipment. Nearly one-third of the medical equipment industry in developing countries is part of the refurbished medical equipment market.
- Besides important environmental benefits, refurbishing provides sustainable economic benefits by creating business and employment in the refurbished medical equipment market. Even existing equipment owners may consider refurbishing their machines rather than disposing of old ones and buying new ones if their users are comfortable using the specific model. A refurbished asset can be re-capitalized on a depreciation schedule at half the value of new equipment. Refurbishment typically costs about half as much as buying a new one and can bring a machine back to like-new. In addition to the initial cost savings, refurbishment increases resale value and can provide tax benefits to a business, depending on how it’s structured.
- Apart from cost savings, user comfort with the machines they’ve been using is a bonus. The global refurbished medical equipment market eliminates the annoying problems faced in using a worn-down machine and avoids the learning curve associated with new equipment. Users often grow fond of their devices and love to see their trusted old machines returned to life in better shape than before. The refurbishment also sometimes allows upgrading to the newest available technology.
Increasing Demand for Medical Equipment in Developing Countries
- The dearth of access to medical equipment in developing countries has attracted global interest in the refurbished medical equipment market for disease diagnosis. Healthcare systems in low-and middle-income countries often have limited access to medical equipment that appears to be in routine use. Implementing medical equipment refurbishment in a developing country would provide employment, increase the knowledge of medical technology among the people, and thus, provide a sustainable supply of skilled personnel for the healthcare industry.
- Medical equipment typically consists of complex machines that are expensive to purchase and operate and require significant maintenance. Smaller clinics and local medical centers may not be inclined to spend many resources purchasing new equipment that can easily deplete their entire annual budget for just a few devices. Purchasing refurbished medical equipment allows healthcare providers to maximize their budget while providing quality treatment options to each patient. By investing in refurbished equipment, hospitals and clinics can free up much-needed funds for other uses, such as staff, disposables, and medicines, further contributing to the growth of the refurbished medical equipment market.
- The environmental benefits of refurbished medical equipment are also worth touting. By extending the useful life of medical equipment from 5–7 to 10–14 years or even more, refurbishment is a form of reuse and waste prevention, contributing to an environmental economy. Refurbishment saves energy, and the materials are used to produce new equipment. Refurbishing medical equipment and extending its service life maximizes the return on the initial investment of energy and materials. Approximately 90% of the material for a system undergoing refurbishment can be reused; only 10% of the material must be recycled, which is done using environmentally friendly processes.
- Preparing the hospital's capital budget is an interesting time because it often puts its executives at odds. There are two crucial points where refurbished medical equipment options can assist in this process. The first: relying on refurbished equipment in the development of capital budgets, as pricing options for refurbished equipment early in the process allow to push the price further while allowing for significant upgrades. Second, refurbished equipment can fill the capital budget gap with low-cost options for equipment.
- In the UK, hospitals are struggling to afford the most advanced scanners and surgical equipment to treat patients who have cancer and other diseases because of multibillion-pound cuts to the NHS’s capital budget. In such cases, the refurbished medical equipment market becomes an ideal choice for hospitals to get the requirements at affordable prices.
- Diagnostic players are entering into outsourcing contracts with hospitals, whereby they would handle the entire diagnostic operations for them. Newly started small hospitals, diagnostic centers, and clinics have a financial burden and cannot dedicate to the new equipment. A few types of medical equipment could easily take up an entire annual budget for a small medical facility. Purchasing refurbished medical equipment is a viable solution contributing to the refurbished medical equipment market. The refurbished medical equipment is upgraded to current standards, ensuring updated equipment for a reasonable price.
- Medical equipment inventory is an accepted cost of doing business for manufacturers and is often the most significant cost category. Since medical equipment is typically a high-value product, any efficiencies or cost reductions can quickly contribute to the bottom line. Older equipment does not last forever, and this equipment eventually will need to be replaced and refurbished. It is expected that many facilities will be eager to replace their older systems with the resolution of global supply chain problems. These factors contribute to the rising sales of medical devices, which reflects a large inventory of used medical equipment in the refurbished medical equipment market.
PRODUCT TYPE INSIGHTS
The global refurbished medical equipment market by product type is segmented into medical imaging, IVD & laboratories, OR, surgical & therapeutic, patient monitoring, cardiology, dental, and others. In 2021, the medical imaging segment dominated the market, accounting for 25.58%. The use of medical diagnostic imaging equipment can resolve between 70 – 80% of diagnostic problems, but nearly 2/3 of the world’s population has no access to diagnostic radiology. Refurbished X-ray machines, ultrasound systems, MRI machines, CT scanners, and nuclear medicine systems (PET, SPECT, and PET/CT) allow healthcare facilities to provide patients with life-saving medical diagnostic imaging services.
The IVD & laboratories equipment segment will likely witness the highest CAGR of 13.14%. Further, the medical imaging equipment segment will account for the highest incremental growth of USD 3.10 billion over the forecast period.
Segmentation by Product Type
- Medical Imaging Equipment
- IVD & Laboratories Equipment
- OR (Operating Room), Surgical and
- Patient Monitoring Equipment
- Cardiology Equipment
- Dental Equipment
- Others
Diagnosis & monitoring and treatment & surgical interventions are the key segments in the global refurbished medical equipment market by application. In 2021, the diagnosis & monitoring segment dominated the market with a share of 69.46%, followed by treatment & surgical interventions. Medical equipment is extensively utilized for patients’ diagnosis and treatment. Diagnostic and monitoring applications comprise Cardiology, Urology, Neurology, Orthopedics, Physiology, Emergency Medicine, Oncology, Obstetrics/Gynecology (OB/GYN), and others.
Arizton predicts that the treatment & surgical interventions segment will likely witness the highest CAGR of 12.40%. The diagnosis & monitoring segment will account for the highest incremental growth of USD 9.73 billion over the forecast period.
Segmentation Application
- Diagnosis & Monitoring
- Treatment & Surgical Interventions
The global refurbished medical equipment market is segmented into hospitals, radiology/medical imaging centers, physicians' offices & dental clinics, clinical & research laboratories, and others by end-user. In 2021, the hospital segment accounted for 37.97% dominating the industry. Arizton predicts that the clinical & research laboratories segment will likely witness the highest CAGR of 12.18%.
The hospital's segment will account for the highest incremental growth of USD 5.24 billion over the forecast period. Hospitals utilize more medical equipment than any other healthcare setting. Diagnostics are the primary screening method in hospitals, which are the first point of contact for any infection and disease. The rising number of people with various infectious diseases encourages physicians in hospitals to use diagnostic imaging equipment, thereby increasing their demand.
Segmentation by End-users
- Hospitals
- Radiology/Medical Imaging Centers
- Clinics, Physician offices & Dental Clinics
- Clinical & Research Laboratories
- Others
The refurbished medical equipment market has a high potential due to low production and material costs, contribution to containing hospital costs, and high growth potential. North America and Europe are the matured market for refurbished medical equipment. In 2021, North America dominated the global refurbished medical equipment market with a share of 28.24%, followed by Europe, APAC, Latin America, and the Middle East & Africa. Arizton predicts that the APAC segment will likely witness the highest CAGR of 14.45% and the highest incremental growth of USD 4.84 billion over the forecast period. Factors associated with the market growth in the region include constant public and private funding, advancements in diagnostic imaging models, and growing medical awareness.
North American refurbished medical equipment market was valued at USD 4.30 billion in 2021.
The North American region is dominating the global refurbished medical equipment market with the aging population, the prevalence of chronic diseases, growing healthcare expenditure, the need for advanced imaging techniques, the presence of well-established players, and a significant shift towards digital medical equipment. Further, the US accounted for 91.21% of the North American refurbished medical equipment market share. One of the major factors driving the demand for refurbished medical equipment in the US is the increasing diseased population, the increasing access to insurance, and the faster adoption of advanced healthcare instruments for treatments.
Segmentation by Geography
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- Turkey
- UAE
The global refurbished medical equipment market is exceptionally active, with fewer global, regional, and local players offering a wide range of medical equipment. The industry is less competitive, as the key players have gained significant refurbished medical equipment market share compared to other prominent players. The market provides the avenue for cheaper access to healthcare delivery and reduces costs in developing countries where these equipment are purchased for use.
The three major manufacturers in the refurbished medical equipment market, GE Healthcare, Koninklijke Philips, and Siemens Healthineers, have implemented the refurbished process and sold their refurbished medical equipment under distinct brand names. In 2021, North America was the largest regional refurbished medical equipment market. It was primarily attributed to the presence of many private healthcare facilities, the increasing aging population, the high prevalence of various diseases, ongoing reimbursement cuts, and regulatory scenarios for the sale and use of refurbished medical equipment in the US.
Key Vendors
- General Electric Company
- Koninklijke Philips
- Siemens Healthineers
- Amber Diagnostics
- Apt Medical Systems
- Avante Health Solutions
- Block Imaging
- EverX
- Future Health Concepts
- Medirays
- Meridian Medical
- PACIFIC HEALTHCARE IMAGING
- Radiology Oncology System
- Soma Tech Intl
- US Med-Equip’s
- US Medical Systems
- Venture Medical ReQuip
1. What is the expected refurbished medical equipment market size by 2027?
2. What is the growth rate of the global refurbished medical equipment market?
3. Who are the key companies in the global refurbished medical equipment market?
4. What are the latest refurbished medical equipment market trends globally?
5. Which region holds the largest refurbished medical equipment market share globally?
Table of Contents
301 Pages
- 1 RESEARCH METHODOLOGY
- 2 RESEARCH OBJECTIVES
- 3 RESEARCH PROCESS
- 4 SCOPE & COVERAGE
- 4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
- 4.2 BASE YEAR
- 4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY THERAPY AREA
- 4.3.2 MARKET SEGMENTATION BY ORIGIN
- 4.3.3 MARKET SEGMENTATION BY PRODUCT
- 4.3.4 MARKET SEGMENTATION BY FUNCTION
- 4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
- 5 REPORT ASSUMPTIONS & CAVEATS
- 5.1 KEY CAVEATS
- 5.2 CURRENCY CONVERSION
- 5.3 MARKET DERIVATION
- 6 MARKET AT A GLANCE
- 7 INTRODUCTION
- 7.1 BACKGROUND
- 7.2 IMPACT OF COVID-19 ON GLOBAL SUPPLY CHAIN
- 8 PREMIUM INSIGHTS
- 9 MARKET OPPORTUNITIES & TRENDS
- 9.1 GROWING DEMAND FOR CLINICAL TRIALS LOGISTICS
- 9.2 DIGITAL TRANSFORMATIONS IN PHARMA LOGISTICS
- 9.3 INCREASING DEMAND FOR CELL & GENE THERAPY LOGISTICS
- 10 MARKET GROWTH ENABLERS
- 10.1 INCREASING DEMAND FOR TEMPERATURE-SENSITIVE MEDICINES
- 10.2 GROWING DEMAND FOR OCEAN FREIGHT SERVICE
- 10.3 INCREASING DEMAND FOR GENERICS AND BIOSIMILARS
- 11 MARKET RESTRAINTS
- 11.1 LACK OF COMPLIANCE AND CHANGING REGULATIONS
- 11.2 IMPACT OF COVID-19 PANDEMIC
- 11.3 GEOPOLITICAL RISKS & CHANGES IN INTERNATIONAL TRADE POLICIES AND RELATIONS
- 12 MARKET LANDSCAPE
- 12.1 MARKET OVERVIEW
- 12.2 MARKET SIZE & FORECAST
- 12.2.1 INSIGHTS BY THERAPY AREA
- 12.2.2 INSIGHTS BY ORIGIN
- 12.2.3 INSIGHTS BY PRODUCT
- 12.2.4 INSIGHTS BY FUNCTION
- 12.2.5 INSIGHTS BY GEOGRAPHY
- 12.3 FIVE FORCES ANALYSIS
- 12.3.1 THREAT OF NEW ENTRANTS
- 12.3.2 BARGAINING POWER OF SUPPLIERS
- 12.3.3 BARGAINING POWER OF BUYERS
- 12.3.4 THREAT OF SUBSTITUTES
- 12.3.5 COMPETITIVE RIVALRY
- 13 THERAPY AREA
- 13.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.2 MARKET OVERVIEW
- 13.3 COMMUNICABLE DISEASES
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 MARKET BY GEOGRAPHY
- 13.4 ONCOLOGY
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 MARKET BY GEOGRAPHY
- 13.5 DIABETES
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 MARKET BY GEOGRAPHY
- 13.6 CARDIOVASCULAR DISEASES
- 13.6.1 MARKET OVERVIEW
- 13.6.2 MARKET SIZE & FORECAST
- 13.6.3 MARKET BY GEOGRAPHY
- 13.7 AUTOIMMUNE DISEASES
- 13.7.1 MARKET OVERVIEW
- 13.7.2 MARKET SIZE & FORECAST
- 13.7.3 MARKET BY GEOGRAPHY
- 13.8 NEUROLOGICAL DISORDERS
- 13.8.1 MARKET OVERVIEW
- 13.8.2 MARKET SIZE & FORECAST
- 13.8.3 MARKET BY GEOGRAPHY
- 13.9 PAIN MANAGEMENT
- 13.9.1 MARKET OVERVIEW
- 13.9.2 MARKET SIZE & FORECAST
- 13.9.3 MARKET BY GEOGRAPHY
- 13.10 RESPIRATORY DISEASES
- 13.10.1 MARKET OVERVIEW
- 13.10.2 MARKET SIZE & FORECAST
- 13.10.3 MARKET BY GEOGRAPHY
- 13.11 OTHERS
- 13.11.1 MARKET OVERVIEW
- 13.11.2 MARKET SIZE & FORECAST
- 13.11.3 MARKET BY GEOGRAPHY
- 14 ORIGIN
- 14.1 MARKET SNAPSHOT & GROWTH ENGINE
- 14.2 MARKET OVERVIEW
- 14.3 BRANDED DRUGS
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 MARKET BY GEOGRAPHY
- 14.4 GENERIC DRUGS
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 MARKET BY GEOGRAPHY
- 14.5 OTC
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 MARKET BY GEOGRAPHY
- 15 PRODUCT
- 15.1 MARKET SNAPSHOT & GROWTH ENGINE
- 15.2 MARKET OVERVIEW
- 15.3 SMALL MOLECULE DRUGS
- 15.3.1 MARKET OVERVIEW
- 15.3.2 MARKET SIZE & FORECAST
- 15.3.3 MARKET BY GEOGRAPHY
- 15.4 BIOLOGICS
- 15.4.1 MARKET OVERVIEW
- 15.4.2 MARKET SIZE & FORECAST
- 15.4.3 MARKET BY GEOGRAPHY
- 15.5 MONOCLONAL ANTIBODIES
- 15.5.1 MARKET OVERVIEW
- 15.5.2 MARKET SIZE & FORECAST
- 15.6 VACCINES
- 15.6.1 MARKET OVERVIEW
- 15.6.2 MARKET SIZE & FORECAST
- 15.7 OTHERS
- 15.7.1 MARKET OVERVIEW
- 15.7.2 MARKET SIZE & FORECAST
- 16 FUNCTION
- 16.1 MARKET SNAPSHOT & GROWTH ENGINE
- 16.2 MARKET OVERVIEW
- 16.3 TRANSPORTATION
- 16.3.1 MARKET OVERVIEW
- 16.3.2 MARKET SIZE & FORECAST
- 16.3.3 MARKET BY GEOGRAPHY
- 16.4 ROAD
- 16.4.1 MARKET OVERVIEW
- 16.4.2 MARKET SIZE & FORECAST
- 16.5 WATER
- 16.5.1 MARKET OVERVIEW
- 16.5.2 MARKET SIZE & FORECAST
- 16.6 AIR
- 16.6.1 MARKET OVERVIEW
- 16.6.2 MARKET SIZE & FORECAST
- 16.7 WAREHOUSING
- 16.7.1 MARKET OVERVIEW
- 16.7.2 MARKET SIZE & FORECAST
- 16.7.3 MARKET BY GEOGRAPHY
- 16.8 OTHERS
- 16.8.1 MARKET OVERVIEW
- 16.8.2 MARKET SIZE & FORECAST
- 16.8.3 MARKET BY GEOGRAPHY
- 17 GEOGRAPHY
- 17.1 MARKET SNAPSHOT & GROWTH ENGINE
- 17.2 GEOGRAPHIC OVERVIEW
- 18 NORTH AMERICA
- 18.1 MARKET OVERVIEW
- 18.2 MARKET SIZE & FORECAST
- 18.3 NORTH AMERICA BY THERAPY AREA
- 18.4 NORTH AMERICA BY ORIGIN
- 18.5 NORTH AMERICA BY PRODUCT
- 18.6 NORTH AMERICA BY FUNCTION
- 18.7 KEY COUNTRIES
- 18.7.1 US: MARKET SIZE & FORECAST
- 18.7.2 CANADA: MARKET SIZE & FORECAST
- 19 EUROPE
- 19.1 MARKET OVERVIEW
- 19.2 MARKET SIZE & FORECAST
- 19.3 EUROPE BY THERAPY AREA
- 19.4 EUROPE BY ORIGIN
- 19.5 EUROPE BY PRODUCT
- 19.6 EUROPE BY FUNCTION
- 19.7 KEY COUNTRIES
- 19.7.1 GERMANY: MARKET SIZE & FORECAST
- 19.7.2 FRANCE: MARKET SIZE & FORECAST
- 19.7.3 UK: MARKET SIZE & FORECAST
- 19.7.4 ITALY: MARKET SIZE & FORECAST
- 19.7.5 SPAIN: MARKET SIZE & FORECAST
- 20 APAC
- 20.1 MARKET OVERVIEW
- 20.2 MARKET SIZE & FORECAST
- 20.3 APAC BY THERAPY AREA
- 20.4 APAC BY ORIGIN
- 20.5 APAC BY PRODUCT
- 20.6 APAC BY FUNCTION
- 20.7 KEY COUNTRIES
- 20.7.1 CHINA: MARKET SIZE & FORECAST
- 20.7.2 JAPAN: MARKET SIZE & FORECAST
- 20.7.3 INDIA: MARKET SIZE & FORECAST
- 20.7.4 SOUTH KOREA: MARKET SIZE & FORECAST
- 20.7.5 AUSTRALIA: MARKET SIZE & FORECAST
- 21 LATIN AMERICA
- 21.1 MARKET OVERVIEW
- 21.2 MARKET SIZE & FORECAST
- 21.3 LATIN AMERICA BY THERAPY AREA
- 21.4 LATIN AMERICA BY ORIGIN
- 21.5 LATIN AMERICA BY PRODUCT
- 21.6 LATIN AMERICA BY FUNCTION
- 21.7 KEY COUNTRIES
- 21.7.1 BRAZIL: MARKET SIZE & FORECAST
- 21.7.2 MEXICO: MARKET SIZE & FORECAST
- 21.7.3 ARGENTINA: MARKET SIZE & FORECAST
- 22 MIDDLE EAST & AFRICA
- 22.1 MARKET OVERVIEW
- 22.2 MARKET SIZE & FORECAST
- 22.3 MIDDLE EAST & AFRICA BY THERAPY AREA
- 22.4 MIDDLE EAST & AFRICA BY ORIGIN
- 22.5 MIDDLE EAST & AFRICA BY PRODUCT
- 22.6 MIDDLE EAST & AFRICA BY FUNCTION
- 22.7 KEY COUNTRIES
- 22.7.1 TURKEY: MARKET SIZE & FORECAST
- 22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
- 22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST
- 23 COMPETITIVE LANDSCAPE
- 23.1 COMPETITION OVERVIEW
- 23.1.1 AMERISOURCEBERGEN
- 23.1.2 DB GROUP
- 23.1.3 DEUTSCHE POST DHL
- 23.1.4 CEVA LOGISTICS
- 23.1.5 UNITED PARCEL SERVICE
- 23.1.6 FEDEX
- 23.1.7 KUEHNE+NAGEL
- 24 KEY COMPANY PROFILES
- 24.1 AMERISOURCEBERGEN
- 24.1.1 BUSINESS OVERVIEW
- 24.1.2 SERVICE OFFERINGS
- 24.1.3 KEY STRATEGIES
- 24.1.4 KEY STRENGTHS
- 24.1.5 KEY OPPORTUNITIES
- 24.2 CEVA LOGISTICS
- 24.2.1 BUSINESS OVERVIEW
- 24.2.2 SERVICE OFFERINGS
- 24.2.3 KEY STRATEGIES
- 24.2.4 KEY STRENGTHS
- 24.2.5 KEY OPPORTUNITIES
- 24.3 DB GROUP
- 24.3.1 BUSINESS OVERVIEW
- 24.3.2 SERVICE OFFERINGS
- 24.3.3 KEY STRATEGIES
- 24.3.4 KEY STRENGTHS
- 24.3.5 KEY OPPORTUNITIES
- 24.4 DEUTSCHE POST DHL
- 24.4.1 BUSINESS OVERVIEW
- 24.4.2 SERVICE OFFERINGS
- 24.4.3 KEY STRATEGIES
- 24.4.4 KEY STRENGTHS
- 24.4.5 KEY OPPORTUNITIES
- 24.5 FEDEX
- 24.5.1 BUSINESS OVERVIEW
- 24.5.2 SERVICE OFFERINGS
- 24.5.3 KEY STRATEGIES
- 24.5.4 KEY STRENGTHS
- 24.5.5 KEY OPPORTUNITIES
- 24.6 KUEHNE + NAGEL
- 24.6.1 BUSINESS OVERVIEW
- 24.6.2 SERVICE OFFERINGS
- 24.6.3 KEY STRATEGIES
- 24.6.4 KEY STRENGTHS
- 24.6.5 KEY OPPORTUNITIES
- 24.7 UNITED PARCEL SERVICE
- 24.7.1 BUSINESS OVERVIEW
- 24.7.2 SERVICE OFFERINGS
- 24.7.3 KEY STRATEGIES
- 24.7.4 KEY STRENGTHS
- 24.7.5 KEY OPPORTUNITIES
- 25 OTHER PROMINENT VENDORS
- 25.1 ABS LOGISTICS
- 25.1.1 BUSINESS OVERVIEW
- 25.1.2 SERVICE OFFERINGS
- 25.2 AWL INDIA
- 25.2.1 BUSINESS OVERVIEW
- 25.2.2 SERVICE OFFERINGS
- 25.3 ALLOGA
- 25.3.1 BUSINESS OVERVIEW
- 25.3.2 SERVICE OFFERINGS
- 25.4 BOLLORÉ LOGISTICS
- 25.4.1 BUSINESS OVERVIEW
- 25.4.2 SERVICE OFFERINGS
- 25.5 CARDINAL HEALTH
- 25.5.1 BUSINESS OVERVIEW
- 25.5.2 SERVICE OFFERINGS
- 25.6 C.H. ROBINSON
- 25.6.1 BUSINESS OVERVIEW
- 25.6.2 SERVICE OFFERINGS
- 25.7 COLD CHAIN TECHNOLOGIES
- 25.7.1 BUSINESS OVERVIEW
- 25.7.2 SERVICE OFFERINGS
- 25.8 CRYOPDP
- 25.8.1 BUSINESS OVERVIEW
- 25.8.2 SERVICE OFFERINGS
- 25.9 DPD
- 25.9.1 BUSINESS OVERVIEW
- 25.9.2 SERVICE OFFERINGS
- 25.10 DSV
- 25.10.1 BUSINESS OVERVIEW
- 25.10.2 SERVICE OFFERINGS
- 25.11 FARMASOFT
- 25.11.1 BUSINESS OVERVIEW
- 25.11.2 SERVICE OFFERINGS
- 25.12 JEENA & COMPANY
- 25.12.1 BUSINESS OVERVIEW
- 25.12.2 SERVICE OFFERINGS
- 25.13 LUFTHANSA CARGO
- 25.13.1 BUSINESS OVERVIEW
- 25.13.2 SERVICE OFFERINGS
- 25.14 A.P. MOLLER - MAERSK
- 25.14.1 BUSINESS OVERVIEW
- 25.14.2 SERVICE OFFERINGS
- 25.15 MEDLINE
- 25.15.1 BUSINESS OVERVIEW
- 25.15.2 SERVICE OFFERINGS
- 25.16 NIPPON EXPRESS
- 25.16.1 BUSINESS OVERVIEW
- 25.16.2 SERVICE OFFERINGS
- 25.17 NOATUM LOGISTICS
- 25.17.1 BUSINESS OVERVIEW
- 25.17.2 SERVICE OFFERINGS
- 25.18 OWENS & MINOR
- 25.18.1 BUSINESS OVERVIEW
- 25.18.2 SERVICE OFFERINGS
- 25.19 OXIMIO
- 25.19.1 BUSINESS OVERVIEW
- 25.19.2 SERVICE OFFERINGS
- 25.20 PHARMA LOGISTICS
- 25.20.1 BUSINESS OVERVIEW
- 25.20.2 SERVICE OFFERINGS
- 25.21 PHOENIX GROUP
- 25.21.1 BUSINESS OVERVIEW
- 25.21.2 SERVICE OFFERINGS
- 25.22 PAREXEL INTERNATIONAL
- 25.22.1 BUSINESS OVERVIEW
- 25.22.2 SERVICE OFFERINGS
- 25.23 SEKO LOGISTICS
- 25.23.1 BUSINESS OVERVIEW
- 25.23.2 SERVICE OFFERINGS
- 25.24 SINGAPORE POST
- 25.24.1 BUSINESS OVERVIEW
- 25.24.2 SERVICE OFFERINGS
- 25.25 SINOTRANS
- 25.25.1 BUSINESS OVERVIEW
- 25.25.2 SERVICE OFFERINGS
- 25.26 XPO LOGISTICS
- 25.26.1 BUSINESS OVERVIEW
- 25.26.2 SERVICE OFFERINGS
- 25.27 YOURWAY
- 25.27.1 BUSINESS OVERVIEW
- 25.27.2 SERVICE OFFERINGS
- 25.28 YUSEN LOGISTICS
- 25.28.1 BUSINESS OVERVIEW
- 25.28.2 SERVICE OFFERINGS
- 26 REPORT SUMMARY
- 26.1 KEY TAKEAWAYS
- 26.2 STRATEGIC RECOMMENDATIONS
- 27 QUANTITATIVE SUMMARY
- 27.1 MARKET BY GEOGRAPHY
- 27.2 MARKET BY THERAPY AREA
- 27.3 MARKET BY ORIGIN
- 27.4 MARKET BY PRODUCT
- 27.5 MARKET BY FUNCTION
- 27.6 NORTH AMERICA BY THERAPY AREA
- 27.7 NORTH AMERICA BY ORIGIN
- 27.8 NORTH AMERICA BY PRODUCT
- 27.9 NORTH AMERICA BY FUNCTION
- 27.10 EUROPE BY THERAPY AREA
- 27.11 EUROPE BY ORIGIN
- 27.12 EUROPE BY PRODUCT
- 27.13 EUROPE BY FUNCTION
- 27.14 APAC BY THERAPY AREA
- 27.15 APAC BY ORIGIN
- 27.16 APAC BY PRODUCT
- 27.17 APAC BY FUNCTION
- 27.18 LATIN AMERICA BY THERAPY AREA
- 27.19 LATIN AMERICA BY ORIGIN
- 27.20 LATIN AMERICA BY PRODUCT
- 27.21 LATIN AMERICA BY FUNCTION
- 27.22 MIDDLE EAST & AFRICA AMERICA BY THERAPY AREA
- 27.23 MIDDLE EAST & AFRICA BY ORIGIN
- 27.24 MIDDLE EAST & AFRICA BY PRODUCT
- 27.25 MIDDLE EAST & AFRICA BY FUNCTION
- 28 APPENDIX
- 28.1 ABBREVIATIONS
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.